Novo Nordisk rivals see room to compete in $100 bln weight-loss drug market

NEW YORK, May 4 (Reuters) - The enormous demand for
weight-loss treatments like Novo Nordisk's Wegovy
could support as many as 10 competing products with annual sales
reaching up to $100 billion within a decade... | 12:42pm

Related Keywords

Germany ,Denmark ,United States ,Danish ,Eli Lilly ,Michele Gershberg ,Zealand Pharma ,Evan Seigerman ,Vipin Garg ,Jamie Kane ,Elias Zerhouni ,Damien Conover ,Toby Chopra ,Boehringer Ingelheim ,Novo Nordisk Wegovy ,Novo Nordisk ,Pfizer ,Pfizer Internal Medicine Research Unit ,York Northwell Health ,Pfizer Inc ,Altimmune Inc ,Amgen Inc ,Reuters ,World Health Organization ,Bill Sessa ,Internal Medicine Research ,World Health ,New York ,Northwell Health ,Novo Nordisk Funded ,Altimmune Chief Executive Vipin ,Michael Erman ,Bill Berkrot , ,